RLYB 0.54 ▼ -4.44% Live Trading Data - Stocknear

Rallybio Corporation

NASDAQ: RLYB · Real-Time Price · USD
0.54
-0.03 (-4.44%)
At close: Sep 26, 2025, 10:59 AM
-4.44%
Bid 0.39
Market Cap 22.41M
Revenue (ttm) 761K
Net Income (ttm) -41.65M
EPS (ttm) -0.93
PE Ratio (ttm) -0.58
Forward PE -0.56
Analyst Hold
Dividends n/a
Ask 0.56
Volume 533,369
Avg. Volume (20D) 2,911,803
Open 0.56
Previous Close 0.57
Day's Range 0.51 - 0.57
52-Week Range 0.22 - 1.24
Beta -1.10
Ex-Dividend Date n/a

About RLYB

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RLYB
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RLYB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Rallybio Corporation is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+3.59%
RLYB stock has given up its prior gain. Rallybio s... Unlock content with Pro Subscription
3 weeks ago
+3.59%
Rallybio shares are trading higher after the company received a $12.5M equity milestone payment from Recursion following the initiation of preclinical studies for REV102.